Amanta Healthcare Limited Raised INR 37.80 Crore Via Anchor Investors Prior To IPO Launch

Mumbai (Maharashtra) [India], August 30: Amanta Healthcare Limited, (“Amanta”, “the Company”) engaged in the development, manufacturing, and marketing of sterile liquid products, including both large and small volume parenterals, secured ₹37.80 crore through its anchor book process on August 29, 2025. According to the exchange filing 06 investors participated in the anchor book offering. The List of Anchorinvestors include:

  1. Bandhan Small Cap Fund
  2. Sanshi Fund-1
  3. Perpetuity Health to Wealth (H2W) Rising Fund
  4. Aarth Growth Fund
  5. Sunrise Investment Trust- Sunrise Investment Opportunities Fund
  6. Finavenue Capital Trust- Finavenue Growth Fund

Amanta Healthcare Limited has allocated a total of 30,00,000Equity Shares to these anchor investors, with each share priced at ₹ 126. 

Beeline Capital Advisors Private Limited is the Book Running Lead Manager to the Issue, while MUFG Intime India Private Limited is Registrar to the Issue.

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

Sameer Sharma

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More
Powered by WordPress | WP Magazine by WP Mag Plus